tilmicosin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5632 | 108050-54-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Semi-synthetic antibiotic
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
| CHEBI has role | CHEBI:36047 | antibacterial drugs |
| CHEBI has role | CHEBI:38215 | calcium channel blockers |
| CHEBI has role | CHEBI:50912 | cardiotoxicant |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | Bovine respiratory disease (BRD) associated with Mannheimia haemolytica | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Pasteurella multocida | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Histophilus somni | Indication |
| Cattle | Respiratory disease at high risk of developing BRD associated with M haemolytica | Indication |
| Sheep | Ovine respiratory disease (ORD) associated with Mannheimia haemolytica | Indication |
| Swine | Swine respiratory disease associated with Actinobacillus pleuropneumoniae | Indication |
| Swine | Swine respiratory disease associated with Pasteurella multocida | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Micotil 300 | Elanco US Inc. | 1 |
| Pulmotil 90 | Elanco US Inc. | 1 |
| Pulmotil 90 and Rumensin 90 | Elanco US Inc. | 2 |
| Pulmotil AC | Elanco US Inc. | 2 |
| Pulmotil AC | Elanco US Inc. | 2 |
| Tilmovet 90 | Huvepharma EOOD | 1 |
| Tilmovet 90 and Rumensin 90 | Huvepharma EOOD | 2 |
| Tilmovet and Monovet | Huvepharma EOOD | 2 |
| Pulmotil and Monovet | Huvepharma EOOD | 2 |
| Tilmovet AC | Huvepharma EOOD | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEBI:195409 | CHEBI |
| CHEMBL1908333 | ChEMBL_ID |
| C052319 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11471 | DRUGBANK_ID |
| C1507994 | UMLSCUI |
| CHEMBL2105782 | ChEMBL_ID |
| 6024 | INN_ID |
| 792797003 | SNOMEDCT_US |
| 96024002 | SNOMEDCT_US |
| 137330-13-3 | SECONDARY_CAS_RN |
| D02492 | KEGG_DRUG |
| 5282521 | PUBCHEM_CID |
| 1294593 | RXNORM |
| XL4103X2E3 | UNII |
Pharmaceutical products:
None